The history of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in income, its intellectual property lapse created a wave of knock-off medications, significantly eroding its dominance. While specific businesses may try to capitalize on related treatments , t